New drug promotes weight loss without muscle loss

A new study led by researchers at the University of California, Berkeley, has shown that a medication called "TOFA," which is taken orally, is capable of achieving significant weight loss in obese mice. The mice lost around 18% of their body weight without reducing their food intake or negatively affecting their muscles. The compound works inside cells to inhibit fat production and stimulate fat burning, while increasing the body's energy expenditure—resulting in weight loss that occurs independently of appetite suppression. The results were even more effective when combined with proven weight-loss drugs, leading to greater reductions in weight and improvements in blood sugar and lipid levels. Additionally, "TOFA" demonstrated efficacy in improving fatty liver disease associated with metabolic disorders without increasing blood triglyceride levels. Although these findings are promising, the study was conducted only on male mice and has not yet been tested on humans, highlighting the need for further research to evaluate safety and effectiveness in people.

Size: 120%Text Size

Notice: This Is an AI-Generated Summary

Display The Full Article